Annual Operating Expenses
$25.71 M
-$31.89 M-55.37%
December 31, 2023
Summary
- As of February 26, 2025, LSTA annual total operating expenses is $25.71 million, with the most recent change of -$31.89 million (-55.37%) on December 31, 2023.
- During the last 3 years, LSTA annual operating expenses has risen by +$6.56 million (+34.28%).
- LSTA annual operating expenses is now -57.15% below its all-time high of $60.00 million, reached on December 1, 2014.
Performance
LSTA Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$5.34 M
-$187.00 K-3.39%
September 30, 2024
Summary
- As of February 26, 2025, LSTA quarterly total operating expenses is $5.34 million, with the most recent change of -$187.00 thousand (-3.39%) on September 30, 2024.
- Over the past year, LSTA quarterly operating expenses has dropped by -$689.00 thousand (-11.44%).
- LSTA quarterly operating expenses is now -85.85% below its all-time high of $37.72 million, reached on September 1, 2022.
Performance
LSTA Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
LSTA Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -55.4% | -11.4% |
3 y3 years | +34.3% | -11.4% |
5 y5 years | +51.3% | -11.4% |
LSTA Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -55.4% | at low | -85.8% | at low |
5 y | 5-year | -55.4% | +34.3% | -85.8% | +31.5% |
alltime | all time | -57.1% | >+9999.0% | -85.8% | +4049.3% |
Lisata Therapeutics Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $5.34 M(-3.4%) |
Jun 2024 | - | $5.52 M(-16.3%) |
Mar 2024 | - | $6.60 M(+9.6%) |
Dec 2023 | $25.71 M(-55.4%) | $6.03 M(+1.0%) |
Sep 2023 | - | $5.96 M(-13.3%) |
Jun 2023 | - | $6.88 M(+0.5%) |
Mar 2023 | - | $6.84 M(+4.6%) |
Dec 2022 | $57.60 M(+98.3%) | $6.54 M(-82.7%) |
Sep 2022 | - | $37.72 M(+461.3%) |
Jun 2022 | - | $6.72 M(+1.5%) |
Mar 2022 | - | $6.62 M(-3.3%) |
Dec 2021 | $29.05 M(+51.7%) | - |
Dec 2021 | - | $6.85 M(-1.7%) |
Sep 2021 | - | $6.97 M(-2.5%) |
Jun 2021 | - | $7.15 M(-11.6%) |
Mar 2021 | - | $8.09 M(+48.5%) |
Dec 2020 | $19.14 M(-4.7%) | $5.45 M(+1.8%) |
Sep 2020 | - | $5.35 M(+24.7%) |
Jun 2020 | - | $4.29 M(+5.8%) |
Mar 2020 | - | $4.06 M(-20.2%) |
Dec 2019 | $20.09 M(+18.3%) | $5.08 M(+0.2%) |
Sep 2019 | - | $5.07 M(-5.1%) |
Jun 2019 | - | $5.35 M(+16.4%) |
Mar 2019 | - | $4.59 M(+21.0%) |
Dec 2018 | $16.99 M(-38.4%) | $3.80 M(+0.9%) |
Sep 2018 | - | $3.76 M(-11.9%) |
Jun 2018 | - | $4.27 M(-17.3%) |
Mar 2018 | - | $5.16 M(-29.5%) |
Dec 2017 | $27.59 M(-6.5%) | $7.32 M(+19.4%) |
Sep 2017 | - | $6.13 M(-20.5%) |
Jun 2017 | - | $7.71 M(+19.9%) |
Mar 2017 | - | $6.43 M(+17.1%) |
Dec 2016 | $29.50 M(-45.3%) | $5.49 M(-4.1%) |
Sep 2016 | - | $5.73 M(-22.7%) |
Jun 2016 | - | $7.41 M(-40.0%) |
Mar 2016 | - | $12.33 M(+50.2%) |
Dec 2015 | $53.90 M(-10.2%) | $8.21 M(-28.3%) |
Sep 2015 | - | $11.46 M(-29.8%) |
Jun 2015 | - | $16.34 M(-8.7%) |
Mar 2015 | - | $17.89 M(+7.4%) |
Dec 2014 | $60.00 M(+55.7%) | $16.67 M(+1.8%) |
Sep 2014 | - | $16.36 M(+23.6%) |
Jun 2014 | - | $13.24 M(-3.5%) |
Mar 2014 | - | $13.73 M(+22.3%) |
Dec 2013 | $38.53 M(+17.6%) | $11.23 M(+11.8%) |
Sep 2013 | - | $10.04 M(+21.1%) |
Jun 2013 | - | $8.29 M(-7.5%) |
Mar 2013 | - | $8.96 M(+9.5%) |
Dec 2012 | $32.77 M(-7.5%) | $8.18 M(-6.7%) |
Sep 2012 | - | $8.78 M(+17.8%) |
Jun 2012 | - | $7.45 M(-10.9%) |
Mar 2012 | - | $8.36 M(-1.2%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2011 | $35.41 M(-8.0%) | $8.46 M(+12.5%) |
Sep 2011 | - | $7.52 M(-28.1%) |
Jun 2011 | - | $10.46 M(-15.6%) |
Mar 2011 | - | $12.39 M(+24.9%) |
Dec 2010 | $38.47 M(+38.8%) | $9.92 M(-9.7%) |
Sep 2010 | - | $10.99 M(+9.9%) |
Jun 2010 | - | $10.00 M(+31.7%) |
Mar 2010 | - | $7.59 M(-45.5%) |
Dec 2009 | $27.73 M(+198.6%) | $13.92 M(+91.6%) |
Sep 2009 | - | $7.26 M(+54.0%) |
Jun 2009 | - | $4.72 M(+151.3%) |
Mar 2009 | - | $1.88 M(-23.3%) |
Dec 2008 | $9.29 M(-12.8%) | $2.45 M(+26.3%) |
Sep 2008 | - | $1.94 M(-18.6%) |
Jun 2008 | - | $2.38 M(-5.7%) |
Mar 2008 | - | $2.52 M(+1.7%) |
Dec 2007 | $10.65 M(+125.8%) | $2.48 M(-42.6%) |
Sep 2007 | - | $4.33 M(+120.7%) |
Jun 2007 | - | $1.96 M(+4.7%) |
Mar 2007 | - | $1.87 M(+7.9%) |
Dec 2006 | $4.71 M(+192.6%) | $1.74 M(+73.6%) |
Sep 2006 | - | $999.80 K(-3.8%) |
Jun 2006 | - | $1.04 M(+10.7%) |
Mar 2006 | - | $939.20 K(+90.7%) |
Dec 2005 | $1.61 M(+8.2%) | $492.50 K(-9.6%) |
Sep 2005 | - | $544.60 K(+51.8%) |
Jun 2005 | - | $358.80 K(+66.5%) |
Mar 2005 | - | $215.50 K(-19.0%) |
Dec 2004 | $1.49 M(+62.7%) | $266.00 K(-36.4%) |
Sep 2004 | - | $418.40 K(+0.7%) |
Jun 2004 | - | $415.50 K(+6.8%) |
Mar 2004 | - | $389.10 K(+3.5%) |
Dec 2003 | $915.40 K(-21.8%) | $376.00 K(+86.8%) |
Sep 2003 | - | $201.30 K(-3.9%) |
Jun 2003 | - | $209.50 K(+62.9%) |
Mar 2003 | - | $128.60 K(-64.5%) |
Dec 2002 | $1.17 M(-28.8%) | $362.30 K(+57.0%) |
Sep 2002 | - | $230.80 K(+12.3%) |
Jun 2002 | - | $205.50 K(-44.7%) |
Mar 2002 | - | $371.40 K(-21.6%) |
Dec 2001 | $1.64 M(-34.6%) | $474.00 K(+22.4%) |
Sep 2001 | - | $387.40 K(+7.8%) |
Jun 2001 | - | $359.30 K(-14.9%) |
Mar 2001 | - | $422.20 K(-38.6%) |
Dec 2000 | $2.51 M(+145.5%) | $687.90 K(-34.0%) |
Sep 2000 | - | $1.04 M(+112.8%) |
Jun 2000 | - | $490.20 K(+63.6%) |
Mar 2000 | - | $299.70 K |
Dec 1999 | $1.02 M(+138.8%) | - |
Dec 1998 | $428.20 K(+93.2%) | - |
Mar 1998 | $221.60 K(-11.9%) | - |
Mar 1997 | $251.60 K(-2.1%) | - |
Mar 1996 | $257.10 K | - |
FAQ
- What is Lisata Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Lisata Therapeutics?
- What is Lisata Therapeutics annual operating expenses year-on-year change?
- What is Lisata Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Lisata Therapeutics?
- What is Lisata Therapeutics quarterly operating expenses year-on-year change?
What is Lisata Therapeutics annual total operating expenses?
The current annual operating expenses of LSTA is $25.71 M
What is the all time high annual operating expenses for Lisata Therapeutics?
Lisata Therapeutics all-time high annual total operating expenses is $60.00 M
What is Lisata Therapeutics annual operating expenses year-on-year change?
Over the past year, LSTA annual total operating expenses has changed by -$31.89 M (-55.37%)
What is Lisata Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of LSTA is $5.34 M
What is the all time high quarterly operating expenses for Lisata Therapeutics?
Lisata Therapeutics all-time high quarterly total operating expenses is $37.72 M
What is Lisata Therapeutics quarterly operating expenses year-on-year change?
Over the past year, LSTA quarterly total operating expenses has changed by -$689.00 K (-11.44%)